Nanhua Bio Medicine Co Ltd (000504) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanhua Bio Medicine Co Ltd (000504) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.42 Million ≈ $3.28 Million USD) by net assets (CN¥362.66 Million ≈ $53.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Nanhua Bio Medicine Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Nanhua Bio Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Nanhua Bio Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nanhua Bio Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanhua Bio Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanxi Antai Group Co Ltd
SHG:600408
|
0.053x |
|
Kolon Life Science Inc
KQ:102940
|
0.007x |
|
Matrix Service Co
NASDAQ:MTRX
|
0.245x |
|
Neosem Inc
KQ:253590
|
0.014x |
|
Hana Tour
KO:039130
|
0.120x |
|
Siamgas and Petrochemicals Public Company Limited
BK:SGP-R
|
0.054x |
|
Nanjing Textiles Import & Export Corp Ltd
SHG:600250
|
0.078x |
|
ABG Sundal Collier Holding ASA
OL:ABG
|
0.051x |
Annual Cash Flow Conversion Efficiency for Nanhua Bio Medicine Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Nanhua Bio Medicine Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 000504 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥357.51 Million ≈ $52.31 Million |
CN¥-115.74 Million ≈ $-16.94 Million |
-0.324x | -2004.44% |
| 2024-12-31 | CN¥282.00 Million ≈ $41.27 Million |
CN¥4.79 Million ≈ $701.45K |
0.017x | -85.72% |
| 2023-12-31 | CN¥304.67 Million ≈ $44.58 Million |
CN¥36.28 Million ≈ $5.31 Million |
0.119x | -94.28% |
| 2022-12-31 | CN¥79.88 Million ≈ $11.69 Million |
CN¥166.38 Million ≈ $24.35 Million |
2.083x | +114.54% |
| 2021-12-31 | CN¥110.32 Million ≈ $16.14 Million |
CN¥107.10 Million ≈ $15.67 Million |
0.971x | +163.00% |
| 2020-12-31 | CN¥134.48 Million ≈ $19.68 Million |
CN¥-207.22 Million ≈ $-30.32 Million |
-1.541x | -1314.43% |
| 2019-12-31 | CN¥114.46 Million ≈ $16.75 Million |
CN¥14.52 Million ≈ $2.13 Million |
0.127x | +190.02% |
| 2018-12-31 | CN¥107.75 Million ≈ $15.77 Million |
CN¥-15.19 Million ≈ $-2.22 Million |
-0.141x | +61.81% |
| 2017-12-31 | CN¥128.43 Million ≈ $18.79 Million |
CN¥-47.40 Million ≈ $-6.94 Million |
-0.369x | -101.57% |
| 2016-12-31 | CN¥79.76 Million ≈ $11.67 Million |
CN¥-14.60 Million ≈ $-2.14 Million |
-0.183x | -115.47% |
| 2015-12-31 | CN¥-14.51 Million ≈ $-2.12 Million |
CN¥-17.17 Million ≈ $-2.51 Million |
1.184x | +125.51% |
| 2014-12-31 | CN¥7.03 Million ≈ $1.03 Million |
CN¥-32.60 Million ≈ $-4.77 Million |
-4.639x | -41.07% |
| 2013-12-31 | CN¥3.57 Million ≈ $522.49K |
CN¥-11.74 Million ≈ $-1.72 Million |
-3.289x | -1699.99% |
| 2012-12-31 | CN¥-20.80 Million ≈ $-3.04 Million |
CN¥-4.28 Million ≈ $-625.68K |
0.206x | +958.05% |
| 2011-12-31 | CN¥130.38 Million ≈ $19.08 Million |
CN¥-3.12 Million ≈ $-457.01K |
-0.024x | +93.96% |
| 2010-12-31 | CN¥161.13 Million ≈ $23.58 Million |
CN¥-63.95 Million ≈ $-9.36 Million |
-0.397x | -195.00% |
| 2009-12-31 | CN¥144.30 Million ≈ $21.12 Million |
CN¥60.28 Million ≈ $8.82 Million |
0.418x | +725.04% |
| 2008-12-31 | CN¥278.16 Million ≈ $40.70 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.067x | -425.61% |
| 2007-12-31 | CN¥449.00 Million ≈ $65.70 Million |
CN¥9.22 Million ≈ $1.35 Million |
0.021x | +1169.29% |
| 2006-12-31 | CN¥443.78 Million ≈ $64.94 Million |
CN¥717.62K ≈ $105.01K |
0.002x | -93.67% |
| 2005-12-31 | CN¥445.86 Million ≈ $65.24 Million |
CN¥11.40 Million ≈ $1.67 Million |
0.026x | -14.73% |
| 2004-12-31 | CN¥443.86 Million ≈ $64.95 Million |
CN¥13.31 Million ≈ $1.95 Million |
0.030x | -77.23% |
| 2003-12-31 | CN¥423.50 Million ≈ $61.97 Million |
CN¥55.75 Million ≈ $8.16 Million |
0.132x | +221.97% |
| 2002-12-31 | CN¥387.30 Million ≈ $56.67 Million |
CN¥15.83 Million ≈ $2.32 Million |
0.041x | -61.50% |
| 2001-12-31 | CN¥322.29 Million ≈ $47.16 Million |
CN¥34.22 Million ≈ $5.01 Million |
0.106x | +1318.35% |
| 2000-12-31 | CN¥385.75 Million ≈ $56.45 Million |
CN¥-3.36 Million ≈ $-491.98K |
-0.009x | +21.76% |
| 1999-12-31 | CN¥173.52 Million ≈ $25.39 Million |
CN¥-1.93 Million ≈ $-282.86K |
-0.011x | -218.50% |
| 1998-12-31 | CN¥352.69 Million ≈ $51.61 Million |
CN¥3.32 Million ≈ $485.17K |
0.009x | -- |
About Nanhua Bio Medicine Co Ltd
Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment engages in the provision of stem cell, immune cell storage and technical services, and medical device trade. The Energy Saving and Environmental Protection segment is involved in the external energy management … Read more